MSR1 and central nervous system cancer: In vitro, CD204 deficiency resulted in the increased expression of M2-like markers (MMP2, TGFβ, MRC2, MGL1, FIZZ1), but no M1-like marker (TNFα) in the presence of GL261 glioma cells (25).